Effect of Fuyuan Huoxue Decoction on Knee Osteoarthritis
Y. Guo,J. Yao,F. Liu,B. Dong,Z. Wang
DOI: https://doi.org/10.1016/j.joca.2021.02.537
IF: 7.507
2021-01-01
Osteoarthritis and Cartilage
Abstract:Purpose: Under the guidance of traditional Chinese medicine, this study observes the clinical effect of Fuyuan Huoxue Decoction in treating patients with knee osteoarthritis of Qi stagnation and blood stasis by grasping the holistic view and dialectical treatment. Methods: From April 2020 to September 2020, 42 patients with qi stagnation and blood stasis knee osteoarthritis in the Department of Orthopedics, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine were selected, and the patients were divided into a control group (21 cases) and treatment using a random number table method In the group (21 cases), there was no statistically significant difference between the two groups of patients in general information such as age, gender, education, and course of disease (P>0.05), and they were comparable. Diagnostic criteria: In line with the Western medicine diagnostic criteria for KOA in the "Guidelines for Knee Osteoarthritis Evidence-Based Medicine" formulated by the American Association of Orthopaedic Surgeons in 2013: ①Knee joint pain occurred multiple times in the past month; ②X-rays showed osteophytes Formation; ③knee joint activity can feel the sound of bone friction; ④morning stiffness time ≤0.5 h; ⑤ synovial fluid examination meets osteoarthritis. It meets the diagnostic criteria of KOA in the "Guiding Principles for Clinical Research of New Chinese Medicines": ①joint pain, waist and knee weakness, and limited mobility; ②red tongue with petechiae, little or white greasy or thin white coating, heavy pulse, Astringent pulse. Inclusion criteria: ①Meet the relevant diagnostic criteria of Chinese and Western medicine; ②Sign the informed consent form and take the medicine according to the doctor's order. Exclusion criteria: ①Combined with organ dysfunction such as heart, liver and kidney; ②Knee joint surgery in the past 6 months; ③Intra-articular fluid and joints with bony ankylosis; ④Knee joint tumors, tuberculosis and secondary knee bony Arthritis; ⑤Pregnant and lactating women; ⑥Unsuccessful puncture to extract at least 0.5 mL of knee joint fluid; ⑦Have taken hormones and non-steroidal anti-inflammatory drugs in the past 1 month; ⑧Used others within 3 months before admission treatment. Patients in the control group took diclofenac sodium sustained-release tablets (Nanjing Yiheng Pharmaceutical Co., Ltd., National Medicine Standard: H20066213), twice a day, 75 mg each time, with warm water after meals; patients in the treatment group were given Fuyuan Huoxue Decoction (bupleurum 15g) , Gualou root 9g, angelica 9g, safflower 6g, licorice 6g, pangolin 6g, wine rhubarb 30g, peach kernel 9g), for severe pain, add Corydalis 12g, green peel 12g; for knee pain and swelling, add Eucommia 9g, and 9g; For severe numbness of lower limbs, add black snake 9g. Patients in both groups were treated for 14 days. The clinical efficacy of the two groups of patients was compared, and the Lysholm knee function score was used to evaluate knee joint function and pain visual analog scale (VAS score). The data results obtained were analyzed using SPSS19.0 software, and the difference was statistically significant with P<0.05. Results: (1) Refer to the "Guiding Principles for Clinical Research of New Chinese Medicines" to formulate efficacy criteria, specifically: clinical symptoms disappear, TCM syndrome score reduction rate≥95%, normal joint activities are clinically controlled; clinical symptoms basically disappear, 70%≤TCM syndrome score reduction rate <95%, joint movement is not restricted as significant effect; clinical symptoms have been improved, 30%≤TCM syndrome score reduction rate <70%, and slight limitation of joint movement is effective; clinical symptoms, joints There is no significant improvement or even aggravation in the activity, and the TCM syndrome score reduction rate<30% is invalid. Total effective rate = (number of clinically controlled cases+number of markedly effective cases + number of effective cases) / total number of cases×100%.(2) Lysholm knee joint function score was used to evaluate knee joint function. The scale includes support, limp, and stability. Sex, noose, pain, going up and down stairs, squatting, each item 0-3 points, a total score of 0-21 points, the higher the score, the better the knee function. There was no difference in knee function scores between the two groups before treatment (P>0.05). After treatment, the knee function scores of the two groups increased, but the knee function scores of the treatment group were significantly higher than those of the control group, and the difference was statistically significant (P <0.05).(3)VAS score: using a sliding scale about 10cm long, 10 scales are marked on one side, one section is marked as "0", the other end is marked as "10", 0 means no pain, 10 means most painful . Before treatment, there was no significant difference in VAS scores between the two groups of patients. After treatment, the VAS scores of the two groups were reduced, but the VAS scores of the patients in the treatment group were significantly lower than those of the control group, and the difference was statistically significant (P<0.05). Conclusions: (1) Fuyuan Huoxue Decoction has significant clinical effects in treating patients with qi stagnation and blood stasis knee osteoarthritis, with a total effective rate of over 90%;(2) Fuyuan Huoxue Decoction can improve the Lysholm knee function score of patients with qi stagnation and blood stasis knee osteoarthritis, improve the functional status of the patient's knee joint, and improve the patient's quality of life;(3) Fuyuan Huoxue Decoction can significantly reduce the VAS score of patients with qi stagnation and blood stasis knee osteoarthritis, and effectively relieve the pain of patients.Tabled 1Comparison of clinical efficacy between two groups of patients (cases)GroupNumber of casesClinical controlmarkedly effectiveeffective ineffectivetotal effective rate (%)Control group21113766.67therapy group21316290.48T4.51P0.02 Open table in a new tab Tabled 1Lysholm knee function score of the two groups of patients (x±s, points)GroupNumber of casesBefore treatmentafter treatmentControl group214.86±1.9410.31±2.65therapy group214.79±1.8513.01±2.92T1.132.73P0.780.01 Open table in a new tab Tabled 1Comparison of VAS scores between the two groups (x±s, points)GroupNumber of casesBefore treatmentafter treatmentControl group215.86±2.142.17±1.35therapy group215.79±2.350.71±0.65T1.052.33P0.910.02 Open table in a new tab